Radboud University Medical Center Becomes First Hospital in the Netherlands to Win HIMSS Stage 7 Award

HIMSS EuropeHIMSS Analytics Europe, subsidiary of HIMSS Europe, has awarded Radboud university medical center with the Stage 7 Award, making it the first HIMSS Stage 7 hospital in the Netherlands and the third in Europe.

The hospital, which has 953 beds, joins the University Medical Centre Hamburg-Eppendorf in Germany and the Hospital de Dénia-Marina Salud in Spain in the highest stage of the European EMR Adoption Model (EMRAM) developed by HIMSS.

The Netherlands enjoy a high number of Stage 6 awarded hospitals, which consolidates this country as one of the European leaders in ehealth. Beside Radboudumc, as of today, 10 Dutch hospitals and university medical centers have achieved Stage 6. Across Europe there are more than 50 hospitals recognized in the Stage 6 category.

EMRAM has been adapted to meet the needs of European healthcare institutions as a methodology for evaluating the progress and impact of electronic medical record systems in hospitals. Tracking their progress in completing eight stages (0‐7), hospitals can review the implementation and utilization of information technology applications with the aim of reaching Stage 7, which represents a superior electronic patient record environment.

Hospitals that reach Stage 7 support the true sharing and use of patient data to improve process performance, quality of care and patient safety. Uwe Buddrus, senior consultant at HIMSS Analytics Europe, said: "Radboudumc is only the third hospital in Europe to achieve the prestigious HIMSS EMRAM Stage 7 Award and the first within two years during which many European hospitals - more than 1100 in Europe, 62 of which in The Netherlands - participated in the EMRAM evaluation. I am very happy that HIMSS has identified another best practice example in Europe, which I am sure will stimulate many other hospitals on their journey towards improving healthcare delivery by the use of hospital IT solutions."

Buddrus adds: "Radboudumc is also the first fully approved member of the HIMSS Stage 6 & 7 Club, and expected to take a leading role in providing continuous evidence of the benefits of IT. Among the many highlights of Radboudumc's achievements since its last evaluation and recognition as Stage 6, I'd like to emphasize their approach towards medication safety, as well as Clinical Decision Support."

For more information on the stage 7 award visit http://himssanalytics.eu/emram/

About HIMSS Analytics Europe
HIMSS Analytics Europe (HAE) provides health care organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. HAE’s offerings include comparative Hospital IT adoption benchmarking, a European‐formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country level and application specific reports also provide insights into major IT adoption trends and applications.

About Radboud university medical centre
Radboud university medical center founded in 1951, is an institute for patient care, research and education & training, located in Nijmegen in the Netherlands. Our mission is to have a significant impact on healthcare. We aim to be a frontrunner in the development of innovative, sustainable and affordable healthcare. We offer excellent quality, participatory and personalised healthcare, operational excellence and sustainable networks. Our almost 10,000 employees and over 3,000 students do their utmost every day to make a positive contribution to the future of healthcare and medical sciences.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...